White Paper
Our work in White Paper
-
The Social Value of Disseminating Transcatheter Aortic Valve Replacement
Transcatheter aortic valve replacement (TAVR) has facilitated treatment of aortic stenosis in patients otherwise ineligible for corrective surgery or who are reluctant to undergo open-heart surgery. Schaeffer Center experts estimate the social value of past and future TAVR procedures.
Categorized in -
Advancing the Economics of Palliative Care: The Value to Individuals and Families, Organizations, and Society
A palliative care research agenda can help lay the foundation for building a strong evidence base to guide public policies meant to advance affordable, equitable, high-quality, patient-centered care.
Categorized in -
Reducing Racial Disparities in Early Cancer Diagnosis With Blood-Based Tests
A new white paper published by the USC Schaeffer Center focuses on multi-cancer, early detection, (MCED) blood-based tests as one solution to reduce disparities in late-stage cancer diagnosis among minority populations.
Categorized in -
COVID-19 Vaccination Mandates for School and Work Are Sound Public Policy
A new Schaeffer Center white paper finds that vaccine mandates for employees and students is an effective policy solution to ensure the U.S. reaches herd immunity and avoids future outbreaks.
Categorized in -
Impacts of First-in-Class Drug Approvals on Future in-Class Innovation
Some claim that FDA approval of drugs with uncertain efficacy today will slow future innovation. In fact, the relationship is much more complex.
Categorized in -
Medicare Advanced Imaging Payment: Dysfunctional Policy Making
Medicare’s experience of paying for outpatient imaging services, particularly expensive advanced imaging such as MRIs, CAT scans, and nuclear scans, has been tumultuous over the last 20 years.
-
Enrollment in Nongroup Health Insurance by Income Group
Slightly more than half of those with incomes below 400% of the federal poverty level (FPL) were enrolled in nongroup policies that constitute minimum essential coverage.
-
Reassessing the Value of Minimally Invasive Technologies in the Era of COVID-19
Minimally invasive technologies are capacity-conserving technologies that could reduce burdens on healthcare providers and hospitals while also shielding patients from unnecessary in-hospital exposure to pathogens.
Categorized in -
Health Technology Assessment in the U.S. – A Vision for the Future
Health technology assessment (HTA) can help achieve the dual health policy goals of ensuring affordability and encouraging innovation.
Categorized in -
Capping Prices or Creating a Public Option: How Would They Change What We Pay for Healthcare?
Sharp and large differences in prices for commercial health insurers and Medicare have led some policymakers to propose a larger public role in determining provider prices in commercial coverage.